News Room

News

BeyondDx initiated research on immune regulation for enhancing immunity in industrial animals.

2023-08-30 17:46:11

"BeyondDX is conducting immune modulation research targeting diseases with high medical unmet needs using its unique immune profiling technique based on iDxGate iCLUST. This research aims to enhance and extend the efficacy of existing vaccines.

 

 

We are currently conducting immune modulation profiling in various industrial animals for candidate substances. Our goal is to conduct field tests in the second half of 2023.

 

 

The global animal pharmaceutical market is projected to reach $62 billion by 2025 (CAGR 6.5%, '20-'25). Among these, the animal immune modulators market is expected to account for a significant 30% share (R&M, Kiwoom Securities Research)."